Marker Therapeutics, Inc.MRKRNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Above historical average, structural decline.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-11.12M
↑ 65% above average
Average (9y)
$-31.60M
Historical baseline
Range
High:$6.04M
Low:$-147.97M
CAGR
-11.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-11.12M | +5.7% |
| 2023 | $-11.79M | +30.6% |
| 2022 | $-17.00M | +56.1% |
| 2021 | $-38.72M | -40.1% |
| 2020 | $-27.63M | -23.2% |
| 2019 | $-22.42M | +84.8% |
| 2018 | $-147.97M | -1209.8% |
| 2017 | $-11.30M | -287.1% |
| 2016 | $6.04M | +117.7% |
| 2015 | $-34.05M | - |